blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2356983

EP2356983 - Circulation of components during homogenization of emulsions [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  05.10.2018
Database last updated on 13.11.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2011/33]
Inventor(s)01 / Rueckl, Harald
Hortgasse 1
36304 Alsfeld / DE
02 / Scheffczik, Hanno
Brueder-Grimm-Strasse 16
35059 Marburg / DE
03 / Santry, Barbara
Derrypatrick
Drumree, Co. Meath / IE
 [2011/33]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2013/08]Carpmaels & Ransford
One Southampton Row London
WC1B 5HA / GB
Former [2011/33]Carpmaels & Ransford
One Southampton Row London
WC1B 5HA / GB
Application number, filing date10252043.403.12.2010
[2011/33]
Priority number, dateUS20090283518P03.12.2009         Original published format: US 283518 P
[2011/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2356983
Date:17.08.2011
Language:EN
[2011/33]
Type: B1 Patent specification 
No.:EP2356983
Date:20.02.2013
Language:EN
[2013/08]
Search report(s)(Supplementary) European search report - dispatched on:EP16.06.2011
ClassificationIPC:A61K9/107, A61K39/39
[2011/33]
CPC:
A61K9/1075 (EP,US); A61K39/39 (EP,KR,US); A61K39/145 (KR);
A61K9/107 (KR,US); A61K9/113 (KR); A61P31/16 (EP);
B01F23/41 (US); B01F25/44 (US); B01F27/2711 (EP,US);
B01F33/811 (EP,US); A61K2039/55566 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2011/33]
TitleGerman:Komponentenzirkulation während der Homogenisierung von Emulsionen[2011/33]
English:Circulation of components during homogenization of emulsions[2011/33]
French:Circulation de composants pendant l'homogénéisation d'émulsions[2011/33]
Examination procedure18.07.2011Amendment by applicant (claims and/or description)
18.07.2011Examination requested  [2011/36]
05.03.2012Despatch of a communication from the examining division (Time limit: M04)
29.05.2012Reply to a communication from the examining division
06.09.2012Despatch of a communication from the examining division (Time limit: M02)
10.09.2012Reply to a communication from the examining division
15.10.2012Communication of intention to grant the patent
20.12.2012Fee for grant paid
20.12.2012Fee for publishing/printing paid
Divisional application(s)EP13155782.9  / EP2638895
EP24164085.3
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.03.2012
Opposition(s)Opponent(s)01  19.11.2013  22.11.2013  ADMISSIBLE
GLAXO SMITHKLINE BIOLOGICALS S.A.
Rue de l'Institut 89
1330 Rixensart / BE
Opponent's representative
Dalton, Marcus Jonathan William, et al, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
 [2016/08]
Former [2014/01]
Opponent(s)01  19.11.2013  22.11.2013  ADMISSIBLE
GLAXO SMITHKLINE BIOLOGICALS S.A.
Rue de l'Institut 89
1330 Rixensart / BE
Opponent's representative
Robertson, James Stuart, et al, et al
GlaxoSmithKline Global Patents CN925.1 980 Great West Road
Brenford Middlesex TW8 9GS / GB
07.01.2014Invitation to proprietor to file observations on the notice of opposition
17.07.2014Reply of patent proprietor to notice(s) of opposition
15.12.2014Date of oral proceedings
25.02.2015Despatch of minutes of oral proceedings
25.02.2015Despatch of communication that the patent will be revoked
18.09.2018Legal effect of revocation of patent [2018/45]
Appeal following opposition07.05.2015Appeal received No.  T0931/15
07.07.2015Statement of grounds filed
18.09.2018Result of appeal procedure: appeal of the proprietor withdrawn
Fees paidRenewal fee
11.12.2012Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMT03.12.2014
AL03.12.2015
LT03.12.2015
LV03.12.2015
SK03.12.2015
MK04.12.2015
SI04.12.2015
MC31.12.2015
RS14.06.2016
IS30.06.2016
[2018/46]
Former [2018/43]MT03.12.2014
LT03.12.2015
LV03.12.2015
SK03.12.2015
MK04.12.2015
SI04.12.2015
MC31.12.2015
RS14.06.2016
IS30.06.2016
Former [2018/40]MT20.02.2013
LT03.12.2015
LV03.12.2015
SK03.12.2015
MK04.12.2015
SI04.12.2015
MC31.12.2015
RS14.06.2016
IS30.06.2016
Former [2016/50]MT20.02.2013
LT03.12.2015
LV03.12.2015
SK03.12.2015
SI04.12.2015
MC31.12.2015
RS14.06.2016
IS30.06.2016
Former [2016/49]MT20.02.2013
LT03.12.2015
LV03.12.2015
SI04.12.2015
MC31.12.2015
RS14.06.2016
IS30.06.2016
Former [2016/39]MT20.02.2013
LT03.12.2015
LV03.12.2015
MC31.12.2015
RS14.06.2016
IS30.06.2016
Former [2016/38]MT20.02.2013
LT03.12.2015
MC31.12.2015
IS30.06.2016
Former [2016/36]MT20.02.2013
LT03.12.2015
MC31.12.2015
Former [2016/33]MT20.02.2013
MC31.12.2015
Former [2015/41]MT20.02.2013
Former [2014/10]deleted
Former [2013/38]BE20.02.2013
Documents cited:Search[Y]WO2004087204  (PFIZER PROD INC [US], et al);
 [Y]EP1574210  (CHIRON CORP [US]);
 [AP]WO2009155401  (NEUROSYSTEC CORP [US], et al);
by applicantUS4060082
 US4340482
 US4413074
 US4432875
 US4473474
 US4473475
 EP0139417
 US4618533
 EP0221046
 US4673504
 US4705753
 WO9004609
 US4943374
 US4964990
 WO9014837
 EP0520618
 US5178765
 US5277812
 US5531893
 WO9737000
 WO9801174
 WO9917820
 US5971953
 US6039872
 US6071406
 US6193077
 WO0122992
 WO02097072
 US6495050
 US6495043
 US6692468
 WO2005089837
 WO2006044463
 US2007014805
 WO2007052155
 WO2007080308
 EP2029170
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.